Carmell Therapeutics Stock Price on August 28, 2024
| CTCX Stock | 0.25 0.01 4.17% |
If you're considering investing in Carmell Stock, it is important to understand the factors that can impact its price. As of today, the current price of Carmell Therapeutics stands at 0.25, as last reported on the 26th of November, with the highest price reaching 0.27 and the lowest price hitting 0.24 during the day. Carmell Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0276, which signifies that the company had a -0.0276% return per unit of risk over the last 3 months. Carmell Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Carmell Therapeutics' Risk Adjusted Performance of (0.03), standard deviation of 14.01, and Mean Deviation of 8.36 to double-check the risk estimate we provide.
At this time, Carmell Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 13.5 M in 2024, whereas Capital Stock is likely to drop 2,194 in 2024. . At this time, Carmell Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 1.78 in 2024, whereas Price Earnings Ratio is likely to drop (2.85) in 2024. Carmell Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Carmell |
Sharpe Ratio = -0.0276
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CTCX |
Estimated Market Risk
| 14.15 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.39 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Carmell Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Carmell Therapeutics by adding Carmell Therapeutics to a well-diversified portfolio.
Price Book 1.9098 | Price Sales 416.5808 | Shares Float 13 M | Earnings Share 0.48 | Shares Short 505.1 K |
Carmell Therapeutics Main Headline on 28th of August 2024
Acquisition by Spenlehauer Gilles of 599 shares of Carmell T... by Spenlehauer Gilles
Filed transaction by Carmell Therapeutics Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Carmell Therapeutics Valuation on August 28, 2024
It is possible to determine the worth of Carmell Therapeutics on a given historical date. On August 28, 2024 Carmell was worth 0.64 at the beginning of the trading date compared to the closed value of 0.54. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Carmell Therapeutics stock. Still, in general, we apply an absolute valuation method to find Carmell Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Carmell Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Carmell Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.74 | 0.74 | 0.60 | 0.65 | 64,816 | |
08/28/2024 | 0.64 | 0.64 | 0.54 | 0.54 | 48,860 |
| 0.57 | 0.64 | 0.54 | 0.55 | 24,775 |
| Backtest Carmell Therapeutics | | | Carmell Therapeutics History | | | Carmell Therapeutics Valuation | Previous | Next |
Carmell Therapeutics Trading Date Momentum on August 28, 2024
| On August 29 2024 Carmell Therapeutics was traded for 0.55 at the closing time. The top price for the day was 0.64 and the lowest listed price was 0.54 . The trading volume for the day was 24.8 K. The trading history from August 29, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 1.85% . The overall trading delta against the current closing price is 5.56% . |
Carmell Therapeutics Fundamentals Correlations and Trends
By evaluating Carmell Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Carmell Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Carmell financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Carmell Therapeutics Stock history
Carmell Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Carmell is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Carmell Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Carmell Therapeutics stock prices may prove useful in developing a viable investing in Carmell Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 11 M | 13.5 M |
Carmell Therapeutics Stock Technical Analysis
Carmell Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Carmell Therapeutics Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Carmell Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Carmell Therapeutics November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Carmell Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Carmell Therapeutics shares will generate the highest return on investment. By undertsting and applying Carmell Therapeutics stock market strength indicators, traders can identify Carmell Therapeutics entry and exit signals to maximize returns
Carmell Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Carmell Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Carmell Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Carmell to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (1.58) | |||
| Total Risk Alpha | (2.95) | |||
| Treynor Ratio | (0.11) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Carmell Stock Analysis
When running Carmell Therapeutics' price analysis, check to measure Carmell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Carmell Therapeutics is operating at the current time. Most of Carmell Therapeutics' value examination focuses on studying past and present price action to predict the probability of Carmell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Carmell Therapeutics' price. Additionally, you may evaluate how the addition of Carmell Therapeutics to your portfolios can decrease your overall portfolio volatility.